Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment
- 1 February 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 163, 394-402
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Calcium channel blockers and dementiaBritish Journal of Pharmacology, 2013
- Synthesis and Biological Evaluation of 3-Benzisoxazolyl-4-indolylmaleimides as Potent, Selective Inhibitors of Glycogen Synthase Kinase-3βMolecules, 2013
- Expression and Pharmacology of Endogenous Cav Channels in SH-SY5Y Human Neuroblastoma CellsPLOS ONE, 2013
- Benzothiazepine CGP37157 and Its Isosteric 2′-Methyl Analogue Provide Neuroprotection and Block Cell Calcium EntryACS Chemical Neuroscience, 2012
- Calcium Dysregulation and Homeostasis of Neural Calcium in the Molecular Mechanisms of Neurodegenerative Diseases Provide Multiple Targets for NeuroprotectionAntioxidants & Redox Signaling, 2011
- Anthracene Based Compounds as New L-type Ca2+Channel Blockers: Design, Synthesis, and Full Biological ProfileJournal of Medicinal Chemistry, 2009
- Identification of Small Molecule Inhibitors of the Mitotic Kinase Haspin by High-Throughput Screening Using a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer AssaySLAS Discovery, 2008
- Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal NetworksNeuron, 2008
- Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasisBrain Research, 2007
- A Widely Applicable, High-Throughput TR-FRET Assay for the Measurement of Kinase Autophosphorylation: VEGFR-2 as a PrototypeSLAS Discovery, 2003